Key result
Dysregulated platelet miRNAs in overweight individuals may predict CAD.
Why the study?
Overweight and obesity drive CAD, creating a need for effective diagnosis in healthy overweight subjects, where platelet miRNAs may serve as diagnostic markers.
Can platelet miRNAs serve as predictive markers for coronary artery disease in healthy overweight/obese individuals?
Can platelet miRNAs serve as predictive markers for coronary artery disease in healthy overweight/obese individuals?
Platelet miRNAs may serve as novel predictive biomarkers for coronary artery disease in overweight and obese populations, potentially aiding in early diagnosis and prevention.
Platelet miRNAs should not yet guide CAD risk assessment in overweight patients; hypothesis-generating review data requires prospective validation.
Obesity and overweight have become a global problem that development of various coronary artery diseases (CAD), such as myocardial infarction, atherosclerosis and congestive heart failure. Effective diagnosis is needed for effective treatment and prevention, particularly in healthy overweight subject. Platelets is an important component of hemostatic balance, that maintains the coagulation physiology. Platelets are involved in different pathological events such as thrombosis and CAD in various inflammatory conditions. There are evidences that highlight an important role of miRNA in regulation of gene expression profiling in platelets. Current hypothesis has shown the likelihood of using miRNAs as diagnostic markers in the event of CAD. This review article describes the association between overweight/obesity and platelets activation in elucidating the gene expression profiling in platelet miRNAs in CAD patient. The application of platelet miRNAs as predictive markers in overweight/obese individuals may become a marginal milestone in the history of this diet-related disorder treatment.
No takes yet. Share an insight, caveat, or question.
Azlan et al. (2019) conducted a review in Coronary artery disease in overweight/obese subjects. Platelet miRNA expression profiling was evaluated. Specific platelet miRNAs are dysregulated during platelet activation in overweight individuals and may serve as predictive biomarkers for coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: